{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:51:43Z","timestamp":1792785103754,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III-ISCII","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Redes tem\u00e1ticas de investigaci\u00f3n cooperative en salud (RETICS)","award":["RD12\/0036\/0056"],"award-info":[{"award-number":["RD12\/0036\/0056"]}]},{"name":"Centro de Investigaci\u00f3n M\u00e9dica en Red Ciber-Cancer","award":["CB16\/12\/00401"],"award-info":[{"award-number":["CB16\/12\/00401"]}],"id":[{"id":"https:\/\/ror.org\/02g87qh62","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Agencia de Gesti\u00f3n de Ayudas Universitarias y de Investigaci\u00f3n (AGAUR) de la Generalitat de Catalunya","award":["2014SGR1077"],"award-info":[{"award-number":["2014SGR1077"]}],"id":[{"id":"https:\/\/ror.org\/01n4pqe45","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Recercaixa 2015","award":["MD088652"],"award-info":[{"award-number":["MD088652"]}]},{"name":"Competitiveness \u2013 Carlos III Institute of Health","award":["CM15\/00061"],"award-info":[{"award-number":["CM15\/00061"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bpobgyn.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T17:45:17Z","timestamp":1504374317000},"page":"14-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":484,"special_numbering":"C","title":["Epidemiology and burden of HPV-related disease"],"prefix":"10.1016","volume":"47","author":[{"given":"Beatriz","family":"Serrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Brotons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3943-0326","authenticated-orcid":false,"given":"Laia","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2017.08.006_bib1","volume":"vol. 100","author":"IARC","year":"2011"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.006_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.bpobgyn.2017.08.006_bib3","series-title":"Human papillomavirus vaccines WHO position paper","author":"World Health Organization (WHO)","year":"2017"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.006_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A\u00a0review of human carcinogens\u2013part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.bpobgyn.2017.08.006_bib5","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.bpobgyn.2017.08.006_bib6","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.006_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2017.08.006_bib8","article-title":"ICO\/IARC information Centre on papillomavirus and cancer (HPV information Centre). Human papillomavirus and related diseases in the world","volume":"19","author":"Bruni","year":"2017","journal-title":"Summ Rep"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.006_bib9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.bpobgyn.2017.08.006_bib10","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.006_bib11","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/ijc.29082","article-title":"EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection","volume":"136","author":"Giuliano","year":"2015","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.006_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11904-014-0224-x","article-title":"HPV and anal cancer in HIV-infected individuals: a review","volume":"11","author":"Schim van der Loeff","year":"2014","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.006_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/OLQ.0b013e3181c94a3b","article-title":"Oral human papillomavirus in healthy individuals: a systematic review of the literature","volume":"37","author":"Kreimer","year":"2010","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.006_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1099\/jgv.0.000727","article-title":"Oral human papillomavirus infection incidence and clearance: a systematic review of the literature","volume":"98","author":"Wood","year":"2017","journal-title":"J\u00a0Gen Virol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2017.08.006_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009-2010","volume":"307","author":"Gillison","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2017.08.006_bib16","series-title":"Cancer Today","author":"Ervik","year":"2016"},{"key":"10.1016\/j.bpobgyn.2017.08.006_bib17","series-title":"Cancer incidence in five Continents, vol. X (electronic version)","year":"2013"},{"issue":"15","key":"10.1016\/j.bpobgyn.2017.08.006_bib18","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.ejca.2013.04.024","article-title":"Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors","volume":"49","author":"Vaccarella","year":"1990","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.bpobgyn.2017.08.006_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.006_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The global burden of cancer 2013","volume":"1","author":"Fitzmaurice","year":"2015","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.006_bib21","first-page":"924","article-title":"International trends in anal cancer incidence rates","volume":"46","author":"Islami","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2017.08.006_bib22","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1007\/s12105-012-0372-5","article-title":"HPV detection methods in head and neck cancer","volume":"6","author":"Venuti","year":"2012","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.bpobgyn.2017.08.006_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13027-017-0129-6","article-title":"Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe","volume":"12","author":"Hartwig","year":"2017","journal-title":"Infect Agent Cancer"},{"issue":"16","key":"10.1016\/j.bpobgyn.2017.08.006_bib24","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","article-title":"Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva","volume":"49","author":"de Sanjos\u00e9","year":"2013","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.bpobgyn.2017.08.006_bib25","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.ejca.2014.07.018","article-title":"Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples","volume":"50","author":"Alemany","year":"2014","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.006_bib26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.28963","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","author":"Alemany","year":"2015","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.006_bib27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.eururo.2015.12.007","article-title":"Role of human papillomavirus in penile carcinomas worldwide","volume":"69","author":"Alemany","year":"2016","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.006_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv403","article-title":"HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients","volume":"108","author":"Castellsagu\u00e9","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2017.08.006_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-13-39","article-title":"Systematic review of the incidence and prevalence of genital warts","volume":"13","author":"Patel","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bpobgyn.2017.08.006_bib30","series-title":"Anogenital warts: incidence, prevalence, self-reported history and quality of life","first-page":"18","author":"Buckley","year":"2016"},{"issue":"Suppl. 5","key":"10.1016\/j.bpobgyn.2017.08.006_bib31","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.006_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of ten years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.bpobgyn.2017.08.006_bib33","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A\u00a0review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.bpobgyn.2017.08.006_bib34","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","article-title":"Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions","volume":"51","author":"Serrano","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bpobgyn.2017.08.006_bib35","unstructured":"World Heath Organization (WHO), WHO department on immunization, vaccines and biologicals, World Health Organization, Geneva, [Internet]. [Cited 2017 July 20]. Available from: http:\/\/www.who.int\/immunization\/en\/."},{"issue":"7","key":"10.1016\/j.bpobgyn.2017.08.006_bib36","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.006_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693417301244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693417301244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T23:13:33Z","timestamp":1657667613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693417301244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":37,"alternative-id":["S1521693417301244"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and burden of HPV-related disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}